Isocitrate dehydrogenase 1/2 mutational analyses and 2-hydroxyglutarate measurements in Wilms tumors

Pediatric Blood and Cancer

Volumn 56, Issue 3, 2011, Pages 379-383

  Rakheja, Dinesh ^a   Mitui, Midori ^b   Boriack, Richard L ^b   DeBerardinis, Ralph J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

Author keywords

2 hydroxyglutarate; Isocitrate dehydrogenase; Wilms tumor

Indexed keywords

2 HYDROXYGLUTARIC ACID; ISOCITRATE DEHYDROGENASE; PROTEIN IDH1; PROTEIN IDH2; UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; CELL TRANSFORMATION; CHILD; CLINICAL ARTICLE; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; INFANT; LIQUID CHROMATOGRAPHY; MALE; MUTATIONAL ANALYSIS; NEPHROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM MASS SPECTROMETRY; TISSUE LEVEL;

CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GLUTARATES; HUMANS; INFANT; ISOCITRATE DEHYDROGENASE; KIDNEY NEOPLASMS; MALE; MUTATION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TANDEM MASS SPECTROMETRY; WILMS TUMOR;

EID: 78651110077     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22697     Document Type: Article

References (45)

1. Struys EA. D-2-Hydroxyglutaric aciduria: Unravelling the biochemical pathway and the genetic defect. J Inherit Metab Dis 2006; 29: 21-29.
2. Van Schaftingen E, Rzem R, Veiga-da-Cunha M. L-2-Hydroxyglutaric aciduria, a disorder of metabolite repair. J Inherit Metab Dis 2009; 32: 135-142.
3. Muntau AC, Roschinger W, Merkenschlager A, et al. Combined D-2- and L-2-hydroxyglutaric aciduria with neonatal onset encephalopathy: A third biochemical variant of 2-hydroxyglutaric aciduria? Neuropediatrics 2000; 31: 137-140.
4. Moroni I, Bugiani M, D'Incerti L, et al. L-2-Hydroxyglutaric aciduria and brain malignant tumors: A predisposing condition? Neurology 2004; 62: 1882-1884.
5. Wilcken B, Pitt J, Heath D, et al. L-2-Hydroxyglutaric aciduria: Three Australian cases. J Inherit Metab Dis 1993; 16: 501-504.
6. Barbot C, Fineza I, Diogo L, et al. L-2-Hydroxyglutaric aciduria: Clinical, biochemical and magnetic resonance imaging in six Portuguese pediatric patients. Brain Dev 1997; 19: 268-273.
7. Ozisik PA, Akalan N, Palaoglu S, et al. Medulloblastoma in a child with the metabolic disease L-2-hydroxyglutaric aciduria. Pediatr Neurosurg 2002; 37: 22-26.
8. Haliloglu G, Jobard F, Oguz KK, et al. L-2-Hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: Neuroimaging findings. Neuropediatrics 2008; 39: 119-122.
9. Aghili M, Zahedi F, Rafiee E. Hydroxyglutaric aciduria and malignant brain tumor: A case report and literature review. J Neurooncol 2009; 91: 233-236.
10. Larnaout A, Amouri R, Neji S, et al. Osteoma of the calvaria in L-2-hydroxyglutaric aciduria. J Inherit Metab Dis 2007; 30: 980.
11. Ward PS, Patel J, Wise DR, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010; 17: 225-234.
12. Gross S, Cairns RA, Minden MD, et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 2010; 207: 339-344.
13. Frezza C, Tennant DA, Gottlieb E. IDH1 mutations in gliomas: When an enzyme loses its grip. Cancer Cell 2010; 17: 7-9.
14. Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009; 462: 739-744.
15. Rogers RE, Deberardinis RJ, Klesse LJ, et al. Wilms tumor in a child with L-2-hydroxyglutaric aciduria. Pediatr Dev Pathol 2010; in press. It is available at
16. Gibson KM, ten Brink HJ, Schor DS, et al. Stable-isotope dilution analysis of D- and L-2-hydroxyglutaric acid: Application to the detection and prenatal diagnosis of D- and L-2-hydroxyglutaric acidemias. Pediatr Res 1993; 34: 277-280.
17. Lu W, Kimball E, Rabinowitz JD. A high-performance liquid chromatography-tandem mass spectrometry method for quantitation of nitrogen-containing intracellular metabolites. J Am Soc Mass Spectrom 2006; 17: 37-50.
18. Struys EA, Jansen EE, Verhoeven NM, et al. Measurement of urinary D- and L-2-hydroxyglutarate enantiomers by stable-isotope-dilution liquid chromatography-tandem mass spectrometry after derivatization with diacetyl-L-tartaric anhydride. Clin Chem 2004; 50: 1391-1395.
19. Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765-773.
20. Green A, Beer P. Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms. N Engl J Med 2010; 362: 369-370.
21. Mardis ER, Ding L, Dooling DJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361: 1058-1066.
22. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807-1812.
23. Struys EA, Verhoeven NM, Jansen EE, et al. Metabolism of gamma-hydroxybutyrate to D-2-hydroxyglutarate in mammals: Further evidence for D-2-hydroxyglutarate transhydrogenase. Metabolism 2006; 55: 353-358.
24. Struys EA, Verhoeven NM, Ten Brink HJ, et al. Kinetic characterization of human hydroxyacid-oxoacid transhydrogenase: Relevance to D-2-hydroxyglutaric and gamma-hydroxybutyric acidurias. J Inherit Metab Dis 2005; 28: 921-930.
25. Steenweg ME, Jakobs C, Errami A, et al. An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: A genotype-phenotype study. Hum Mutat 2010; 31: 380-390.
26. Topcu M, Jobard F, Halliez S, et al. L-2-Hydroxyglutaric aciduria: Identification of a mutant gene C14orf160, localized on chromosome 14q22. 1. Hum Mol Genet 2004; 13: 2803-2811.
27. Rzem R, Veiga-da-Cunha M, Noel G, et al. A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci USA 2004; 101: 16849-16854.
28. Topcu M, Aydin OF, Yalcinkaya C, et al. L-2-Hydroxyglutaric aciduria: A report of 29 patients. Turk J Pediatr 2005; 47: 1-7.
29. Barth PG, Hoffmann GF, Jaeken J, et al. L-2-Hydroxyglutaric acidaemia: Clinical and biochemical findings in 12 patients and preliminary report on L-2-hydroxyacid dehydrogenase. J Inherit Metab Dis 1993; 16: 753-761.
30. Kranendijk M, Struys EA, Gibson KM, et al. Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduria. Hum Mutat 2009; 31: 279-283.
31. Struys EA, Korman SH, Salomons GS, et al. Mutations in phenotypically mild D-2-hydroxyglutaric aciduria. Ann Neurol 2005; 58: 626-630.
32. Struys EA, Salomons GS, Achouri Y, et al. Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am J Hum Genet 2005; 76: 358-360.
33. Read MH, Bonamy C, Laloum D, et al. Clinical, biochemical, magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (1H MRS) findings in a fourth case of combined D- and L-2 hydroxyglutaric aciduria. J Inherit Metab Dis 2005; 28: 1149-1150.
34. Angle B, Burton BK. Risk of sudden death and acute life-threatening events in patients with glutaric acidemia type II. Mol Genet Metab 2008; 93: 36-39.
35. Yee WC. Two eminently treatable genetic metabolic myopathies. Neurol India 2008; 56: 333-338.
36. Yazici N, Sarialioglu F, Alkan O, et al. L-2-Hydroxyglutaric aciduria and brain tumors: A case report and review of the literature. J Pediatr Hematol Oncol 2009; 31: 865-869.
37. Rakheja D. L-2-Hydroxyglutaric aciduria and multiple acyl-coenzyme A dehydrogenase deficiency are distinct metabolic disorders. J Pediatr Hematol Oncol 2010; 32: 169-170.
38. Murugan AK, Bojdani E, Xing M. Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer. Biochem Biophys Res Commun 2010; 393: 555-559.
39. Bleeker FE, Lamba S, Leenstra S, et al. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 2009; 30: 7-11.
40. National Center for Biotechnology Information Single Nucleotide Polymorphism Database.
41. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000; 287: 848-851.
42. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000; 26: 268-270.
43. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001; 69: 49-54.
44. Tomlinson IP, Alam NA, Rowan AJ, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002; 30: 406-410.
45. Ruteshouser EC, Robinson SM, Huff V. Wilms tumor genetics: Mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer 2008; 47: 461-470.